ViCentra
PrivateLast Round
Series D
Extension
Jan 8, 2026
Total Funding Raised
$207.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ViCentra is a medical device company that develops and manufactures the Kaleido insulin patch pump system, a small and light wearable device designed for people with diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViCentra Comparables
Compare ViCentra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MicroTech | 81% | |
| EOFlow Co., Ltd. | 80% | |
| Terumo Corporation | 76% | |
ViCentra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jan 8, 2026 | ||||
| Series D | Sep 3, 2025 | ||||
| Series C | Dec 16, 2021 | ||||
| Corporate Funding | Jun 30, 2020 | ||||
| Series B | Jan 16, 2016 |
ViCentra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Corporate Funding |
| Venturing Tech | Series D, Series D Extension |
| EQT Life Sciences | Series C, Series D, Corporate Funding, Series B |
| Invest-NL | Series C, Series D, Corporate Funding |
| ROM Utrecht Region | Series D, Series D Extension |
| Kreos Capital | Corporate Funding |
| Partners in Equity | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Mediq named as a distribution partner.
- May 4, 2026
Kaleido system integrates with Diabeloop's DBLG1/DBLG2 algorithm.
ViCentra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViCentra's valuation, stock price, and market status.